Literature DB >> 13359547

Hibicon in treatment of epileptics with mental disorder.

D W MARTIN, S MERLIS.   

Abstract

Entities:  

Keywords:  ANTICONVULSANTS/therapeutic use; EPILEPSY/complications; MENTAL DISORDERS/complications

Mesh：

Substances：

Year:  1956        PMID： 13359547     DOI： 10.1007/bf01564354

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN： 0033-2720


× No keyword cloud information.
  3 in total

1.  Results in the treatment of 54 cases of epilepsy with hibicon; a new anti-convulsant; a preliminary report.

Authors:  N GOTTEN; C D HAWKES; A R TYRER
Journal:  Trans Am Neurol Assoc       Date:  1951

2.  N-Benzyl-beta-chloropropionamide (hibicon); a new approach to anticonvulsant therapy.

Authors:  C D HAWKES
Journal:  AMA Arch Neurol Psychiatry       Date:  1952-06

3.  The pharmacology of N-benzyl-beta-chloropropionamide (hibicon), a new anticonvulsant.

Authors:  B K HARNED; R W CUNNINGHAM; M C CLARK; C H HINE; M M KANE; F H SMITH; R E VESSEY; N N YUDA; F W ZABRANSKY
Journal:  J Pharmacol Exp Ther       Date:  1953-04       Impact factor: 4.030
  3 in total
  3 in total

1.  Nydrane as an anticonvulsant.

Authors:  N KAYE; I H JONES; G K WARRIER
Journal:  Br Med J       Date:  1959-03-07

2.  Beclamide in intractable epilepsy: a controlled trial.

Authors:  J WILSON; J N WALTON; D J NEWELL
Journal:  Br Med J       Date:  1959-05-16

3.  Effects of nydrane on epilepsy in mental defectives.

Authors:  D S SHARPE; G DUTTON; J R MIRREY
Journal:  Br Med J       Date:  1958-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.